A narrative systematic review of associations and temporality between use of methamphetamine, ecstasy/MDMA, or cocaine with anxiety or depressive symptoms.
Duncan Z, Ward B, Kippen R, Dietze P, Sutton K
Alcohol and Other Drugs
A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.
Faber BW, Yeoh LM, Kurtovic L, Mol WEM, Poelert M, Smits E, Rodriguez Garcia R, Mandalawi-Van der Eijk M, van der Werff N, Voorberg-van der Wel A, Remarque EJ, Beeson JG, Kocken CHM.
Malaria
Characteristics of attrition within the SuperMIX cohort of people who inject drugs: A multiple event discrete-time survival analysis.
Abdelsalam S, Agius PA, Sacks-Davis R, Roxburgh A, Livingston M, Maher L, Hickman M, Dietze P
Injecting Drug Use Alcohol and Other Drugs
Using serological diagnostics to characterize remaining high-incidence pockets of malaria in forest-fringe Cambodia.
Grimée M, Tacoli C, Sandfort M, Obadia T, Taylor AR, Vantaux A, Robinson LJ, Lek D, Longley RJ, Mueller I, Popovici J, White MT, Witkowski B
Malaria
WHO hepatitis C elimination targets: the global equity challenge.
Heath K, Hill A
Hepatitis C Global Infectious Disease Threats
Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy.
Hearps AC, Vootukuru N, Ebrahimnezhaddarzi S, Harney BL, Boo I, Nguyen L, Pavlyshyn D, Dietze PM, Drummer HE, Thompson AJ, Jaworowski A, Hellard ME, Sacks-Davis R, Doyle JS
Injecting Drug Use Hepatitis C